Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion

被引:10
作者
Becker, Hans Jiro [1 ,2 ]
Ishida, Reiko [2 ]
Wilkinson, Adam C. [3 ]
Kimura, Takaharu [1 ]
Lee, Michelle Sue Jann [4 ,5 ]
Coban, Cevayir [4 ,5 ]
Ota, Yasunori [6 ,7 ]
Tanaka, Yosuke
Roskamp, Meike [8 ]
Sano, Tsubasa [9 ]
Tojo, Arinobu [10 ]
Kent, David G. [11 ]
Yamazaki, Satoshi [1 ,2 ]
机构
[1] Tsukuba Univ, Fac Med, Lab Stem Cell Therapy, Tsukuba 3058577, Japan
[2] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Therapy, Div Stem Cell Biol, Tokyo 1088639, Japan
[3] Univ Oxford, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford OX3 9DS, England
[4] Univ Tokyo, Inst Med Sci, Div Malaria Immunol, Tokyo 1088639, Japan
[5] Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo 1088639, Japan
[6] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Pathol, Tokyo 1088639, Japan
[7] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto 8600811, Japan
[8] BASF SE, Pharm Solut, Nutr & Hlth, Carl Bosch Str 38, D-67056 Ludwigshafen, Germany
[9] BASF Japan Ltd, Pharm Solut, Nutr & Hlth, Tokyo 1030022, Japan
[10] Tokyo Med & Dent Univ, Tokyo 1138510, Japan
[11] Univ York, York Biomed Res Inst, Dept Biol, Wentworth Way, York YO10 5DD, England
基金
日本科学技术振兴机构; 日本学术振兴会;
关键词
T-CELL; SOLUPLUS(R); REPERTOIRE; MUTATION; MOUSE; DNA;
D O I
10.1016/j.stem.2023.06.002
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Gene editing using engineered nucleases frequently produces unintended genetic lesions in hematopoietic stem cells (HSCs). Gene-edited HSC cultures thus contain heterogeneous populations, the majority of which either do not carry the desired edit or harbor unwanted mutations. In consequence, transplanting edited HSCs carries the risks of suboptimal efficiency and of unwanted mutations in the graft. Here, we present an approach for expanding gene-edited HSCs at clonal density, allowing for genetic profiling of individual clones before transplantation. We achieved this by developing a defined, polymer-based expansion system and identifying long-term expanding clones within the CD201+CD150+CD48-c-Kit+Sca-1+Lin- population of precultured HSCs. Using the Prkdcscid immunodeficiency model, we demonstrate that we can expand and profile edited HSC clones to check for desired and unintended modifications, including large deletions. Transplantation of Prkdc-corrected HSCs rescued the immunodeficient phenotype. Our ex vivo manipulation platform establishes a paradigm to control genetic heterogeneity in HSC gene editing and therapy.
引用
收藏
页码:987 / +
页数:23
相关论文
共 57 条
  • [41] In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
    Pattabhi, Sowmya
    Lotti, Samantha N.
    Berger, Mason P.
    Singh, Swati
    Lux, Christopher T.
    Jacoby, Kyle
    Lee, Calvin
    Negre, Olivier
    Scharenberg, Andrew M.
    Rawlings, David J.
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 277 - 288
  • [42] R Core Team, 2020, R LANG ENV STAT COMP
  • [43] Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model
    Rahman, Shamim H.
    Kuehle, Johannes
    Reimann, Christian
    Mlambo, Tafadzwa
    Alzubi, Jamal
    Maeder, Morgan L.
    Riedel, Heimo
    Fisch, Paul
    Cantz, Tobias
    Rudolph, Cornelia
    Mussolino, Claudio
    Joung, J. Keith
    Schambach, Axel
    Cathomen, Toni
    [J]. PLOS GENETICS, 2015, 11 (05):
  • [44] Chemically defined cytokine-free expansion of human haematopoietic stem cells
    Sakurai, Masatoshi
    Ishitsuka, Kantaro
    Ito, Ryoji
    Wilkinson, Adam C.
    Kimura, Takaharu
    Mizutani, Eiji
    Nishikii, Hidekazu
    Sudo, Kazuhiro
    Becker, Hans Jiro
    Takemoto, Hiroshi
    Sano, Tsubasa
    Kataoka, Keisuke
    Takahashi, Satoshi
    Nakamura, Yukio
    Kent, David G.
    Iwama, Atsushi
    Chiba, Shigeru
    Okamoto, Shinichiro
    Nakauchi, Hiromitsu
    Yamazaki, Satoshi
    [J]. NATURE, 2023, 615 (7950) : 127 - +
  • [45] Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
    Schiroli, Giulia
    Ferrari, Samuele
    Conway, Anthony
    Jacob, Aurelien
    Capo, Valentina
    Albano, Luisa
    Plati, Tiziana
    Castiello, Maria C.
    Sanvito, Francesca
    Gennery, Andrew R.
    Bovolenta, Chiara
    Palchaudhuri, Rahul
    Scadden, David T.
    Holmes, Michael C.
    Villa, Anna
    Sitia, Giovanni
    Lombardo, Angelo
    Genovese, Pietro
    Naldini, Luigi
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (411)
  • [46] The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
    Sharma, Rajiv
    Dever, Daniel P.
    Lee, Ciaran M.
    Azizi, Armon
    Pan, Yidan
    Camarena, Joab
    Koehnke, Thomas
    Bao, Gang
    Porteus, Matthew H.
    Majeti, Ravindra
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] CRISPR therapies march into clinic, but genotoxicity concerns linger
    Sheridan, Cormac
    [J]. NATURE BIOTECHNOLOGY, 2021, 39 (08) : 897 - 899
  • [48] Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Term Hematopoietic Stem Cells
    Tomellini, Elisa
    Fares, Iman
    Lehnertz, Bernhard
    Chagraoui, Jalila
    Mayotte, Nadine
    MacRae, Tara
    Bordeleau, Marie-Eve
    Corneau, Sophie
    Bisaillon, Richard
    Sauvageau, Guy
    [J]. CELL REPORTS, 2019, 28 (04): : 1063 - +
  • [49] Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases
    Tsai, Shengdar Q.
    Joung, J. Keith
    [J]. NATURE REVIEWS GENETICS, 2016, 17 (05) : 300 - 312
  • [50] CD201 and CD27 identify hematopoietic stem and progenitor cells across multiple murine strains independently of Kit and Sca-1
    Vazquez, Sara E.
    Inlay, Matthew A.
    Serwold, Thomas
    [J]. EXPERIMENTAL HEMATOLOGY, 2015, 43 (07) : 578 - 585